{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:31:49Z","timestamp":1766579509245,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clindermatol.2020.12.018","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T21:05:23Z","timestamp":1608152723000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Is the BCG vaccine a useful tool against COVID-19?"],"prefix":"10.1016","volume":"39","author":[{"given":"Galina","family":"Zhelezova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Mateeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grisha","family":"Mateev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.12.018_bib0001","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0365","article-title":"Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered","volume":"10","author":"Dye","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0002","unstructured":"World Health Organization. WHO tuberculosis key facts 2020. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed on 2 Aug 2020."},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0003","first-page":"113","article-title":"Targeting skin dendritic cells to improve intradermal vaccination","volume":"351","author":"Romani","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(83)90044-2","article-title":"Changes in BCG strains","volume":"64","author":"Osborn","year":"1983","journal-title":"Tubercle"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-64371-7_8","article-title":"Evolution and strain variation in BCG","volume":"1019","author":"Abdallah","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0007","first-page":"789","article-title":"Tuberculosis vaccines","author":"Smith","year":"2012","journal-title":"Vaccines"},{"year":"1999","series-title":"World Health Organization. Issues relating to the use of BCG in immunization programmes: A discussion document","author":"Fine","key":"10.1016\/j.clindermatol.2020.12.018_bib0008"},{"year":"2020","series-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19","key":"10.1016\/j.clindermatol.2020.12.018_bib0009"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0010","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0011","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0012","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis"},{"year":"2020","series-title":"Can the BCG vaccine protect against COVID-19?","key":"10.1016\/j.clindermatol.2020.12.018_bib0014"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0016","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.vaccine.2005.12.044","article-title":"Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina","volume":"24","author":"Bonifachich","year":"2006","journal-title":"Vaccine."},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0017","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0018","first-page":"216","article-title":"Tuberculosis Control Program and Expanded Programme on Immunization: Efficacy of infant BCG immunization","year":"1986","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0019","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJM199910143411609","article-title":"Exogenous reinfection in tuberculosis","volume":"341","author":"Fine","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0021","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pntd.0000442","article-title":"Do antenatal parasite infections devalue childhood vaccination?","volume":"3","author":"Labeaud","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0022","first-page":"153","article-title":"Bacille Calmette-Gu\u00e9rin vaccine","volume":"2","author":"Starke","year":"1991","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0023","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ije\/26.4.888","article-title":"A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar","volume":"26","author":"Bertolli","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0024","first-page":"532","article-title":"Protective effect of BCG against leprosy and its subtypes: A case-control study in southern Vietnam","volume":"62","author":"Thuc","year":"1994","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0027","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1586\/era.11.163","article-title":"Role of bacillus Calmette-Guerin in the treatment of advanced melanoma","volume":"11","author":"JHt","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1333906","article-title":"BCG and protection against inflammatory and auto-immune diseases","volume":"16","author":"Kowalewicz-Kulbat","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0029","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0030","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: A beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: Beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0032","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact","volume":"31","author":"Biering-Sorensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0033","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: A randomized controlled trial","volume":"65","author":"Biering-Sorensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0034","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S0034-89101992000400004","article-title":"Risk factors for death caused by pneumonia in children younger than 1 year old in a metropolitan region of southeastern Brazil. A case-control study","volume":"26","author":"Niobey","year":"1992","journal-title":"Revista Saude Publica"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0036","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1017\/S0950268814001368","article-title":"Lack of BCG vaccination and other risk factors for bacteraemia in severely malnourished children with pneumonia","volume":"143","author":"Chisti","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0037","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Guerin (BCG)-vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0038","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen IgakkaiZasshi [Jap J Geriatr]"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0039","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indonesiana"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0040","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: A randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0041","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0042","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0044","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000356035","article-title":"A prime time for trained immunity: Innate immune memory in newborns and infants","volume":"105","author":"Levy","year":"2014","journal-title":"Neonatology"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0046","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0047","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: A randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0048","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fimmu.2017.00644","article-title":"Whole blood profiling of Bacillus Calmette-Guerin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB\/BB, and natural killer cell activation","volume":"8","author":"Smith","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0049","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/infdis\/jiaa030","article-title":"Neonatal BCG vaccination reduces interferon-gamma responsiveness to heterologous pathogens in infants from a randomized controlled trial","volume":"221","author":"Freyne","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0050","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: Implication for vaccine design","volume":"10","author":"Covian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0051","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/all.14345","article-title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0052","unstructured":"Does BCG vaccination protect against acute respiratory infections and COVID-19? 2020. A rapid review of current evidence. Available at: https:\/\/www.cebm.net\/covid-19\/does-bcg-vaccination-protect-against-acute-respiratory-infections-and-covid-19-a-rapid-review-of-current-evidence\/. Accessed on 2 Aug 2020."},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0053","first-page":"131","article-title":"A multicountry level comparison of BCG vaccination policy and COVID-19 cases and mortality","volume":"6","author":"Katbi","year":"2020","journal-title":"J Infect Dis Epidemiol"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0054","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0055","unstructured":"ClinicalTrials.gov. Efficacy of BCG vaccination in the prevention of COVID19 via the strengthening of innate immunity in health care workers (COVID-BCG). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04384549. Accessed on 2 Aug 2020."},{"year":"2020","series-title":"COVID-19, Catch Health Tehnology Review. Ongoing trials for BCG vaccines in prevention of COVD-19","key":"10.1016\/j.clindermatol.2020.12.018_bib0056"},{"key":"10.1016\/j.clindermatol.2020.12.018_bib0057","unstructured":"VPM1002 tuberculosis vaccine. VPM1002 tuberculosis vaccine description. 2020. Available at: https:\/\/www.precisionvaccinations.com\/vaccines\/vpm1002-tuberculosis-vaccine. Accessed on 26 Jly 2020"},{"year":"2020","series-title":"ICMR to launch study to evaluate efficacy of BCG vaccine against coronavirus COVID-19 in elderly","key":"10.1016\/j.clindermatol.2020.12.018_bib0058"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20302534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20302534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:36Z","timestamp":1760033916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20302534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0738081X20302534"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.12.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the BCG vaccine a useful tool against COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}